Irma Veberic, general manager of Roche Hungary, gives her insights on the key issues being faced by the Hungarian healthcare system and the company’s role as a partner in improving health outcomes and raising life expectancy in the country. Veberic goes on to highlight the affiliate’s strong contribution to Hungary through investments in clinical trials and a new pharmacovigilance centre.
An important change that must happen in Hungary’s healthcare ecosystem is the implementation of patient registries and the collection and utilization of health data
